Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influencing factors of drug treatment efficacy in functional dyspepsia
ChiCTR2400079677Phase 4Recruiting
- Sponsor
- Affiliated Hospital of North Sichuan Medical College
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of omeprazole and flupentixol + melitracen in functional dyspepsia (FD) (4 arms), sponsored by Affiliated Hospital of North Sichuan Medical College. Primary endpoints: Dyspepsia Symptom Severity Scale and Short-Form Nepean Dyspepsia Index. Started Jan 2024; status: recruiting.
02
Drugs
omeprazoleflupentixol + melitracen
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on ChiCTR2400079677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079677.